omniture
云顶新耀医药科技有限公司 EVEREST MEDICINES

Latest News

Everest Medicines Announces Half-Year 2021 Interim Results

SHANGHAI, Aug. 30, 2021 /PRNewswire/ -- Everest Medicines

2021-08-30 22:15 2304

Everest Medicines Announces Up to HK$100 million Share Repurchase Program

SHANGHAI, Aug. 30, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical compa...

2021-08-30 22:03 1808

Everest Medicines to Announce Half-Year 2021 Interim Results

SHANGHAI, Aug. 23, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical compa...

2021-08-23 15:20 1741

Everest Medicines Announces Strategic Commercial Partnership with Global Technology Company, Tencent

SHANGHAI, July 12, 2021 /PRNewswire/ -- Everest Medicines

2021-07-12 12:42 2654

Everest Medicines Receives Orphan Drug Designation from the Ministry of Food and Drug Safety in South Korea for Sacituzumab Govitecan-Hziy in Metastatic Triple-Negative Breast Cancer

SHANGHAI, May 6, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical compa...

2021-05-06 08:30 1973

Everest Medicines Appoints Jennifer Yang as Chief Scientific Officer

SHANGHAI, April 15, 2021 /PRNewswire/ -- Everest Medicines

2021-04-15 08:36 3335

Everest Medicines Announces Financial Results for Full Year Ended December 31, 2020

SHANGHAI, March 22, 2021 /PRNewswire/ -- Everest Medicines

2021-03-22 15:06 1535
12